Envoy Medical Awarded Patent for Recharge System used with Implantable Battery
Envoy Medical, Inc. - Class A (COCH)
Company Research
Source: GlobeNewswire
Growing Portfolio of Patents Further Advances the Company’s Mission to Develop Fully Implanted Devices for Those Suffering from Significant Hearing Loss WHITE BEAR LAKE, Minnesota, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a hearing health company focused on fully implanted hearing systems, today announces it has been awarded another patent from the US Patent & Trademark Office for its fully implanted devices. On September 3rd, the Company was issued Patent No. 12,081,061, “Recharge System for Implantable Battery,” which relates to predicting a cumulative thermal dose associated with charging an implantable rechargeable energy storage device to a fully charged state and adjusting the amount of current provided to the device during charging. In other words, this can be used to maintain a safe temperature of an implanted rechargeable battery during recharging. “We are pleased to continue to add to our growing portfolio of patents
Show less
Read more
Impact Snapshot
Event Time:
COCH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COCH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COCH alerts
High impacting Envoy Medical, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
COCH
News
- Envoy Medical Reports Third Quarter 2024 Results and Other Exciting EventsGlobeNewswire
- Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed PublicationGlobeNewswire
- Envoy Medical Receives Another European Patent for its Modular Cochlear Implant SystemGlobeNewswire
- Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing DeviceGlobeNewswire
- Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare CoverageGlobeNewswire
COCH
Analyst Actions
- 9/3/24 - Ascendiant Capital
COCH
Sec Filings
- 11/21/24 - Form 4
- 11/21/24 - Form 4
- 11/20/24 - Form 8-K
- COCH's page on the SEC website